Finance

Lists
7JK:FRA
EQL Pharma AB
€2.30
+1.54%
(+0.035) 1D
Sep 4, 9:55:02 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 7JK...
Open
€2.30
High
€2.30
Low
€2.30
Mkt. cap
755.96M
Avg. vol.
2.00
Volume
0.00
52-wk high
€7.97
52-wk low
€1.66
No. of employees
65
Open
€2.30
High
€2.30
Low
€2.30
Mkt. cap
755.96M
Avg. vol.
2.00
Volume
0.00
52-wk high
€7.97
52-wk low
€1.66
No. of employees
65
About EQL Pharma AB
CEOAxel Schörling
Employees65
Founded2006
Headquarters-
SectorHealth care provider
Websiteeqlpharma.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
86.38M
118.90M
120.17M
106.91M
Cost of goods sold
53.97M
68.61M
86.18M
89.07M
Cost of revenue
53.97M
68.61M
86.18M
89.07M
Research and development expenses
4.51M
3.89M
3.10M
4.27M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
24.41M
28.33M
26.32M
27.71M
Operating expense
28.82M
30.77M
29.78M
31.45M
Total operating expenses
82.79M
99.38M
115.96M
120.52M
Operating income
3.59M
19.52M
4.21M
-13.62M
Other non operating income
-1.00K
-
-4.10M
1.00K
EBT including unusual items
-4.24M
12.33M
-2.27M
-21.10M
EBT excluding unusual items
-4.24M
12.33M
-3.18M
-21.10M
Income tax expense
-871.00K
2.54M
1.44M
-4.35M
Effective tax rate
20.57%
20.60%
-63.51%
20.60%
Other operating expenses
-100.00K
-1.45M
359.00K
-530.00K
Net income
-3.36M
9.79M
-3.72M
-16.75M
Net profit margin
-3.89%
8.23%
-3.09%
-15.67%
Earnings per share
-0.11
0.33
-0.13
-0.03
Interest and investment income
-
-
5.00K
-
Interest expense
-7.82M
-7.20M
-3.29M
-7.48M
Net interest expenses
-7.82M
-7.20M
-3.28M
-7.48M
Depreciation and amortization charges
-
-
-
-
EBITDA
5.67M
24.84M
6.40M
-9.08M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps